Genotype A1/A2 associated with neuroleptic malignant syndrome.
Del Tacca
M
M
Lattanzi
L
L
Lastella
M
M
Di Paolo
A
A
Mungai
F
F
Danesi
R
R
Menichetti
F
F
Dell'osso
L
L
Cassano
G B
GB
D000328:Adult; D000483:Alleles; D014150:Antipsychotic Agents / Q000009:adverse effects; D015283:Citalopram / Q000009:adverse effects; D017931:DNA Primers / Q000235:genetics; D003865:Major Depressive Disorder / Q000188:drug therapy; D006801:Humans; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology / Q000235:genetics*; D016133:Polymerase Chain Reaction; D017448:Receptors, Dopamine D2 / Q000235:genetics*; D018967:Risperidone / Q000009:adverse effects; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects
D014150:Antipsychotic Agents; D015283:Citalopram; D017931:DNA Primers; D017448:Receptors, Dopamine D2; D018967:Risperidone; D017367:Selective Serotonin Reuptake Inhibitors